28332-04-9 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 17 carbon (C) atoms, 16 hydrogen (H) atoms, and 4 nitrogen (N) atoms.
Explanation
This describes the specific arrangement of atoms and bonds in the molecule, which is a triazole derivative with an amine group and a phenylmethyl substituent.
Explanation
The compound is derived from a triazole, which is a five-membered ring containing three nitrogen atoms and two carbon atoms.
Explanation
The molecule contains an amine group (-NH2), which is a functional group consisting of a nitrogen atom bonded to two hydrogen atoms.
Explanation
The molecule has a phenylmethyl group (C6H5-CH2-) attached to it, which is a phenyl group (C6H5) with a methyl group (-CH3) attached to it.
Explanation
Due to its structural features, the compound may exhibit biological activity and could be used in the development of new drugs or as a building block for other organic compounds with medicinal or biological relevance.
Explanation
More research and study are needed to fully understand the properties, potential uses, and any possible side effects or limitations of 1H-1,2,4-Triazol-3-amine, 5-phenyl-1-(phenylmethyl)-.
Chemical Structure
1H-1,2,4-Triazol-3-amine, 5-phenyl-1-(phenylmethyl)-
Triazole Derivative
Yes
Amine Group
Present
Phenylmethyl Substituent
Present
Potential Applications
Medicinal chemistry and pharmaceuticals
Further Research
Required
Check Digit Verification of cas no
The CAS Registry Mumber 28332-04-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,3,3 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 28332-04:
(7*2)+(6*8)+(5*3)+(4*3)+(3*2)+(2*0)+(1*4)=99
99 % 10 = 9
So 28332-04-9 is a valid CAS Registry Number.
28332-04-9Relevant academic research and scientific papers
ORGANIC COMPOUNDS
-
Page/Page column 58, (2010/02/17)
The invention relates to compounds of formula (I): where A is an optionally substituted heteroaryl, useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods
